Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2015 | Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma | Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; LIANG-IN LIN ; Tseng L.-H.; Cheng M.-L.; Liau J.-Y.; Jeng Y.-M. | Modern Pathology | 25 | 21 | |
2006 | Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1] | Chen C.-Y.; LIANG-IN LIN ; Tang J.-L.; Tsay W.; Chang H.-H.; Yeh Y.-C.; Huang C.-F.; Chiou R.-J.; Yao M.; Ko B.-S.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Tien H.-F. | Leukemia | 31 | 35 | |
2009 | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients | Chou W.-C.; Chen C.-Y.; Hou H.-A.; LIANG-IN LIN ; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. | Leukemia | 42 | 40 | |
1994 | Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients | Hsu H.?C.; Peng S.?Y.; Lai P.?L.; Sheu J.?C.; Chen D.?S.; LIANG-IN LIN ; Slagle B.L.; Butel J.S. | Cancer | 53 | ||
2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | Tang J.-L.; Hou H.-A.; Chen C.-Y.; Liu C.-Y.; Chou W.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; LIANG-IN LIN ; Tien H.-F. | Blood | 219 | 210 | |
1994 | The amplification refractory mutation system (ARMS): A rapid and direct prenatal diagnostic technique for β?thalassaemia in Singapore | Tan J.A.M.A.; Tay J.S.H.; LIANG-IN LIN ; Kham S.K.Y.; Chia J.N.; Chin T.M.; Adb. Aziz N.Bt.; Wong H.B. | Prenatal Diagnosis | 39 | ||
1992 | Analysis of hemoglobin gamma chain in patients with Cooley's anemia in Taiwan. | LIANG-IN LIN ; Lin K.S.; Lin D.T. | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
2008 | Anticancer activity of botanical alkyl hydroquinones attributed to topoisomerase II poisoning | Huang C.-P.; Fang W.-H.; LIANG-IN LIN ; Chiou R.Y.; Kan L.-S.; Chi N.-H.; Chen Y.-R.; Lin T.-Y.; Lin S.-B. | Toxicology and Applied Pharmacology | 14 | 12 | |
2016 | Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission | Wang Y.-M.; Lu J.-W.; Lin C.-C.; Chin Y.-F.; Wu T.-Y.; LIANG-IN LIN ; Lai Z.-Z.; Kuo S.-C.; Ho Y.-J. | Antiviral Research | 44 | 38 | |
2018 | Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay | Su K.-Y.; Lai H.-M.; Goodman S.D.; Hu W.-Y.; Cheng W.-C.; LIANG-IN LIN ; Yang Y.-C.; Fang W.-H. | DNA Repair | 4 | 4 | |
2012 | Autophagy: Resetting glutamine-dependent metabolism and oxygen consumption | Lin T.-C.; Chen Y.-R.; Kensicki E.; Li A.Y.-J.; Kong M.; Li Y.; Mohney R.P.; Shen H.-M.; Stiles B.; Mizushima N.; LIANG-IN LIN ; Ann D.K. | Autophagy | 39 | 33 | |
2016 | BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer | Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; LIANG-IN LIN ; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. | Medical Oncology | 14 | 14 | |
2016 | Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) | Lu J.-W.; Wang A.-N.; Liao H.-A.; Chen C.-Y.; Hou H.-A.; Hu C.-Y.; Tien H.-F.; Ou D.-L.; LIANG-IN LIN | Cancer Letters | 14 | 12 | |
2011 | CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia | Lin T.-C.; Hou H.-A.; Chou W.-C.; Ou D.-L.; Yu S.-L.; Tien H.-F.; LIANG-IN LIN | Leukemia | 31 | 30 | |
1990 | Cell type-specific protein-DNA interactions in the human ζ-globin upstream promoter region: Displacement of Sp1 by the erythroid cell-specific factor NF-E1 | Yu C.-Y.; Chen J.; LIANG-IN LIN ; Tam M.; Shen C.-K.J. | Molecular and Cellular Biology | 27 | ||
2015 | Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations | Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; LIANG-IN LIN ; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. | Anticancer Research | 4 | 4 | |
2008 | Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD | Hou H.-A.; Chou W.-C.; LIANG-IN LIN ; Chen C.-Y.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; Tien H.-F. | Leukemia | 43 | 44 | |
2005 | Characterization of CEBPA mutations in acute myeloid leukemia: Most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells | LIANG-IN LIN ; Chen C.-Y.; Lin D.-T.; Tsay W.; Tang J.-L.; Yeh Y.-C.; Shen H.-L.; Su F.-H.; Yao M.; Huang S.-Y.; Tien H.-F. | Clinical Cancer Research | 147 | 152 | |
2006 | Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy | Ou D.-L.; Chen C.-L.; Lin S.B.; Hsu C.-H.; LIANG-IN LIN | Journal of Pathology | 59 | 50 | |
2019 | Chemotherapy agents induce tartrate-resistant acid phosphatase 5a contributing to the symptom distress in lung cancer patients | Chou H.-L.; Chao T.-Y.; Chen T.-C.; Chu C.-M.; Hsieh C.-H.; LIANG-IN LIN ; Yao C.-T. | European Journal of Pharmacology | 0 | 0 |